Direct Meds GLP-1 Reviews: What We Found When We Read the Fine Print

By the WPG Research Team · Weight Loss Provider Guide, an independent comparison resource for GLP-1 telehealth providers
Last verified: August 27, 2026

Advertising disclosure: We may earn a commission if you use a link on this page. It costs you nothing extra and it did not change a single finding below. Direct Meds did not see, review, or approve this page before we published it.

Direct Meds is a real operating telehealth company, not a fake storefront. It sells compounded semaglutide and tirzepatide starting at $249 a month, including needle-free drops you put under your tongue. But our verdict on Direct Meds GLP-1 reviews is “verify before you pay,” not an automatic yes — because the FDA sent Direct Meds a warning letter on September 9, 2025 over claims that made its compounded products sound like FDA-approved drugs, and today its own checkout pages still list “FDA approved for long term weight loss” as a feature of compounded products.

That single sentence is the whole reason this page exists.

Here’s what we mean. We didn’t just read reviews. We opened the FDA warning letter, the terms and conditions, the live product pages, the Better Business Bureau complaint file, Trustpilot, and the FDA’s official list of registered 503B outsourcing facilities. Then we put them side by side. Some things checked out. Some things didn’t. And one thing became even stranger when two Direct Meds pages described the pharmacy network in two different ways: one said 503A, while another said 503B.

Use the one-screen verdict now, or jump to the section you need. By the end, you’ll know exactly what Direct Meds says it sells, what the current pages say you may be charged, and the questions to put in writing before you hand over a card.

Jump to the nine things to confirm before you pay.

Direct Meds GLP-1 reviews: the verdict in one screen

Provider-stated vs. independently checked

Is Direct Meds legit, or is it a scam?

Direct Meds is a real, operating telehealth company. The FDA warning letter identifies directmeds.com, Inc. dba DirectMeds in Bluffdale, Utah. The BBB lists Direct Meds LLC in Salt Lake City, Utah, with a May 6, 2024 start and incorporation date. Direct Meds names clinical staff and publishes a state-by-state pharmacy map. Its site also displays a LegitScript certification claim, although we did not independently confirm the certification’s current status. “Real” is not the same as “everything on the website is accurate,” and that distinction is where most of the confusion comes from.

Let’s get the scam question out of the way first, because it’s what most people are really asking.

This is not an anonymous page that takes a card and disappears. Direct Meds has named business records, a public FDA letter, a BBB file, more than 14,000 Trustpilot reviews, published support numbers, and named pharmacy partners. Reviewers describe receiving medication and dealing with support. Those facts show an operating business.

So no. Not a fake storefront.

But here’s what tripped our radar.

Their own website can’t agree on how many customers they have

We counted the customer numbers used in Direct Meds’ own marketing and in one dated affiliate promotion. We found seven published totals, including six that were still live on current Direct Meds pages and one April 2026 affiliate article.

All live-page figures were checked August 27, 2026. The 125,000 figure is a dated affiliate-article snapshot. These are marketing counts, not independently audited patient totals. Sources for the added snapshots: current Direct Meds promotional page and April 9, 2026 affiliate article.

And the star rating does the same thing. The homepage says 4.6. The FAQ says 4.8. The checkout portal says 4.5.

We’re not saying anyone lied. Marketing pages get built at different times and nobody goes back to sync them. It happens.

But it tells you something useful: don’t make a three-payment decision based on any number printed in a Direct Meds marketing block. Use the terms. Use the checkout screen. Use the price and plan length you actually see. We’ll show you how to read all three.

Watch out for lookalike “Direct Meds” domains

This one matters more than the numbers.

The company named in the FDA letter and linked from the BBB and Trustpilot profiles uses directmeds.com.

When we searched for Direct Meds reviews, we found other domains using the name or calling themselves an official site:

None of them is directmeds.com.

Before you type in your health history or a card number anywhere, look at the address bar and make sure it says exactly directmeds.com. That takes two seconds and it’s one of the simplest safety checks on this page.

What did the FDA warning letter say?

On September 9, 2025, the FDA sent directmeds.com, Inc. dba DirectMeds a warning letter, reference number 716822, saying claims about its compounded semaglutide and tirzepatide were false or misleading because they made the products sound the same as FDA-approved drugs. It was a marketing and labeling action, not a recall. The letter did not allege that a product was contaminated or counterfeit.

This is the part almost no other review page covers properly, so we’re going to be precise.

What the FDA actually objected to

The FDA reviewed directmeds.com in August 2025. It quoted three claims from the site. All three said some version of the same thing: compounded medication used the same active ingredient as the brand-name drug in a way that implied the products were the same.

Here is the heart of the FDA’s response:

“Compounded drug products are not FDA-approved. Your claims imply that your products are the same as an FDA-approved product when they are not.”

The FDA said those claims made the compounded products misbranded under federal drug law. It gave Direct Meds 15 working days to answer and warned that failure to fix violations could lead to enforcement, including seizure or an injunction.

The letter was signed by the Director of the FDA’s Center for Drug Evaluation and Research.

What the warning letter does NOT mean

Let’s be fair, because this gets exaggerated online.

The letter did not say:

• That any Direct Meds medication was fake, dirty, or dangerous
• That any product was recalled
• That any pharmacy was unlicensed
• That Direct Meds had to shut down
• That customers were harmed

It was about words on a website. Specifically, words that made a non-approved product sound approved.

That’s still serious. It’s just serious in a specific way, and you deserve to know which way.

Here’s the part that made us stop

The FDA’s complaint was that Direct Meds implied its compounded products were the same as FDA-approved products.

On August 27, 2026 — almost a year later — we opened the live portal page for compounded sublingual semaglutide at directmeds.com/portal/products/semaglutide-sublingual. This is a page where you pick a dose and plan.

Under “Features,” it still says the product is “FDA approved for long term weight loss.”

On a compounded product. On the buy page.

The same page also says “High bioavailability (89%)” and calls the treatment a “Long acting GLP-1 receptor antagonist.” “Antagonist” is the wrong word. Semaglutide acts as a GLP-1 receptor agonist.

The tirzepatide product page carries the same FDA-approval claim. It also says “Easy-to-use, prefilled pen device,” even though the page is selling a compounded product and does not establish that every prescription arrives in a brand-style prefilled pen.

Meanwhile other current Direct Meds pages say, correctly, that compounded medications are not FDA-approved.

We cannot tell you why the conflicting copy is still live. We can tell you it is still live.

And we’re not going to pretend we didn’t see it, and neither should you.

One question. Ask it before you pay:

“Is the exact medication you will ship me FDA-approved, or is it compounded? Please answer in writing.”

For the semaglutide and tirzepatide programs reviewed on these pages, the correct answer is “compounded.” If anyone tells you that the compounded product itself is FDA-approved, stop and walk away. That’s not a close call.

Primary source: FDA warning letter to directmeds.com, Inc. dba DirectMeds, MARCS-CMS 716822, September 9, 2025. Live product-page wording verified August 27, 2026.

Are Direct Meds medications FDA-approved?

No. The Direct Meds semaglutide and tirzepatide products reviewed on this page are compounded drugs, not FDA-approved drugs. The FDA has not reviewed each specific compounded preparation for safety, effectiveness, quality, manufacturing, or labeling the way it reviews an approved product such as Wegovy, Ozempic, Zepbound, or Mounjaro. Direct Meds states the non-approved status correctly elsewhere on its site, even though the portal copy contradicts it.

If you only read one section, make it this one. It’s the difference between knowing what you bought and guessing.

The plain-English version

An FDA-approved drug has a specific application, evidence package, manufacturing process, labeling, dose forms, and inspection history reviewed through the FDA approval system. The approved label tells clinicians and patients what the product is approved to treat, how it should be used, and what risks are known.

A compounded drug is prepared by a pharmacy for a patient or, in some cases, by a registered outsourcing facility. The FDA does not approve the finished compounded drug. There is no FDA-approved label for that exact preparation. A pharmacy may be licensed and still sell a product that is not FDA-approved.

A 503A pharmacy generally compounds for an identified patient based on a prescription and is primarily overseen by state pharmacy regulators, subject to federal conditions. A 503B outsourcing facility chooses to register with the FDA and may compound certain drugs in batches under a different federal framework. Neither label means the finished medicine is FDA-approved.

Here’s the side-by-side:

That last row is the one people get wrong most often. The big weight-loss studies tested specific products and formulations. They did not test every compounded vial or bottle from every telehealth company. Anyone who treats those as interchangeable evidence is skipping the part that matters.

Where the law stands right now

This part changed a lot recently, and it affects every compounded GLP-1 company, not just Direct Meds.

• The FDA declared the national semaglutide and tirzepatide shortages resolved. The temporary shortage-related enforcement periods for routine copies ended in 2025.
• Under 503A, a pharmacy generally cannot regularly compound a drug that is essentially a copy of a commercially available approved drug. A prescriber may document that a change creates a significant difference for an identified patient.
• Under 503B, outsourcing facilities generally face limits on compounding from bulk drug substances unless the substance qualifies under the statute, including the shortage or 503B bulks-list pathways.
• On April 30, 2026, the FDA proposed not adding semaglutide, tirzepatide, and liraglutide to the 503B bulks list because it found no clinical need for outsourcing facilities to compound them from bulk substances.
• The public comment deadline was extended to July 30, 2026. In our official-source search through August 27, 2026, we found the proposal and extension, but not a published final determination. A proposal is not a final rule.
• A lower cash price by itself is not the same as a patient-specific clinical difference under the FDA’s compounding framework.

Translation: the shortage ending did not make every patient-specific compounded GLP-1 prescription automatically unlawful. But the legal path is narrower than “the brand costs too much, so make a copy.” Your prescriber and pharmacy should be able to tell you what is being compounded, for whom, under which section, and why that preparation is appropriate.

Primary sources: FDA policy for compounders after the GLP-1 shortages; FDA’s April 30, 2026 503B proposal; Federal Register extension through July 30, 2026.

How much does Direct Meds actually cost?

Direct Meds currently lists $249 a month for sublingual semaglutide drops, $297 a month for semaglutide injections, and $399 a month for tirzepatide injections. Promotional pages advertise a first month as low as $147 for semaglutide and $199 for tirzepatide. The detail that changes the answer is the plan you select: Direct Meds says month-to-month plans exist, while the live sublingual semaglutide and tirzepatide portal pages we opened showed a 90-day supply billed monthly.

Now for the number that actually matters.

The current price list

Verified on Direct Meds pages August 27, 2026. “Monthly” does not tell you how much medication ships in one box or whether a remaining plan balance survives cancellation. The checkout terms do.

The per-day math on the two portal pages now matches a 31-day division: $249 ÷ 31 is about $8.03, and $399 ÷ 31 is about $12.87. That is marketing math, not a separate charge. The monthly plan price is the number that belongs in your budget.

The $147 is a first payment, not a full treatment price

This is the single most misunderstood thing about Direct Meds, and it sits behind a large share of the billing complaints we read. We’re going to walk it slowly.

Direct Meds’ current pages describe more than one plan structure:

• An official offer page says month-to-month pricing has no contract.
• The same page says subscribe-and-save plans require an agreed subscription length.
• The live sublingual semaglutide and tirzepatide portal pages showed a 90-day supply billed every month.
• The tirzepatide portal showed only a 90-day choice in the plan selector while a nearby badge said “30, 90, 180, or 360 Day Supply.”
• In an August 6, 2026 BBB response, Direct Meds said it offers 90-day subscription programs with a discounted first payment and later installments. In a separate company response, it explained that a selected 90-day commitment ships up front and is billed monthly.

So there is no honest one-line answer that applies to every Direct Meds checkout.

Here is the clean version:

For the live 90-day portal options we checked, the list-price math is simple:

WPG calculation: monthly price × 3. Your actual promotion or plan may use a different first payment, so copy the exact schedule shown at checkout.

One BBB reviewer said they paid $147, received three months in one shipment, and then learned the next installment was $297. Direct Meds answered a similar review by saying a month-to-month option exists and that a 90-day commitment ships up front and bills monthly. The complaint is one customer’s account. The plan explanation is the company’s own response.

This isn’t a rumor. It is a plan choice you need to identify before paying.

Here’s our one honest knock on Direct Meds — and why it might not matter to you

The problem is not that Direct Meds never offers month-to-month. It says it does. The problem is that its live pages do not present one clean, consistent plan story. One page says month-to-month. Two portal pages show a 90-day supply billed monthly. “Cancel Anytime” sits next to both kinds of language.

If a true one-month option is what you want, choose a checkout that clearly says month-to-month and shows no later balance. If that choice is not visible for your product and state, use our guide to GLP-1 programs with no monthly commitment instead. We mean that. Go there.

But if you already know you want a 90-day plan, the structure may be fine for you.

Longer treatment is common because approved GLP-1 dose schedules usually increase over time. But people also stop early because of side effects, a provider’s advice, cost, pregnancy plans, surgery, or a change in treatment. Flexibility has real value. A lower rate does not erase that.

You just deserve to know which plan you are buying before you click, not after the second charge posts.

👉 See the full plan total before you commit

Open the live Direct Meds checkout and stop before payment. Write down the plan name, supply length, charge today, future charges, total balance, and cancellation deadline. Do not rely on the price in an ad.

See current Direct Meds pricing and plan choices →

A licensed provider must review your history before prescribing. Direct Meds’ semaglutide and tirzepatide products reviewed here are compounded and are not FDA-approved.

Is Direct Meds a subscription, and can you really cancel?

Direct Meds marketing says “No Monthly Membership” and “Cancel Anytime,” while its terms describe subscription products charged every 30 days. An official offer page also says both month-to-month and subscribe-and-save plans exist. All of those statements can be true at once: there may be no separate membership fee, but the medication plan can still renew, and canceling future shipments may not erase a balance for a longer supply already dispensed.

We found five versions of the cancellation story across Direct Meds’ own pages. Here they are, all five:

All of that is from Direct Meds. None of it depends on an angry customer being right.

The three clocks you’re actually racing

This is the clearest way we found to think about it. There are three separate clocks, and they do different things.

Clock 1 — The 24-hour order clock.
The terms say you may try to cancel a prescription order within 24 hours of placing it if the provider network has not received it. After 24 hours, prescription orders generally cannot be canceled. This is the narrow window to try to stop a new prescription order.

Clock 2 — The 48-hour renewal clock.
To stop the next subscription processing, turn off auto-refill in your portal at least 48 hours before the next processing date. The terms say Direct Meds gives notice five to seven days before each charge. This is your window to stop the next renewal when no committed balance remains.

Clock 3 — The selected-plan balance.
If you selected a 90-day plan and the pharmacy already dispensed and shipped all 90 days, Direct Meds’ BBB response says the remaining installments may still be due. This is the one people do not expect.

“Cancel anytime” can be true for future month-to-month shipments. It does not automatically mean “erase every payment tied to medication already dispensed.” That gap is where many billing fights begin.

Other things in the contract worth knowing

We read the whole thing, last updated April 16, 2026. Four clauses aren’t mentioned in the main marketing and probably should be:

• §6: The terms say you waive the right to fill the prescription at another pharmacy. Under this agreement, you cannot take that prescription to CVS or another pharmacy.
• §6: The terms say prescriptions do not use child-resistant packaging. That matters if children live in or visit your home.
• §18: The terms cap total liability at $1,000 and require claims within one year, to the extent the clause is enforceable.
• §22: The terms call for individual arbitration in Salt Lake City, Utah, with a class-action waiver and no jury trial.

And one small useful detail: charges show up on your statement as “DM2*Directmeds.” Now you know what you’re looking at.

How to cancel, with a paper trail

If you’re here because a charge already showed up, this part is for you. No sales pitch. Just do this:

1. Log into your patient portal and turn off auto-refill.
2. Screenshot it. Keep the date and time visible.
3. Email help@directmeds.com the same day and ask for cancellation confirmation in writing.
4. Call (888) 696-7176. For messaging help, the terms also list (833) 949-8998. Note the time and the representative’s name.
5. Ask for four things in writing: the final charge, any remaining plan balance, the last shipment, and the effective cancellation date.
6. Watch your statement for “DM2*Directmeds.”
7. If you believe a charge was not authorized, contact your card issuer promptly enough to preserve any dispute deadline. A card dispute does not decide whether a valid contract balance exists, so keep the plan and cancellation records too.

If charges continue after that, you have a dated paper trail. Of 272 BBB complaints on file, 89 showed a “Resolved” status when we checked. That proves some consumers reported a resolution through the BBB process. It does not guarantee the same result for you.

Primary source: Direct Meds Terms & Conditions, last updated April 16, 2026.

What pharmacy does Direct Meds use? (This is where it got interesting)

Direct Meds publishes a state-by-state pharmacy map naming CraftedRx in Warrenton, Missouri for 42 states plus Washington, DC, and ChemistryRx in Folcroft, Pennsylvania for six states. But the company’s own pages conflict on the federal category: one live page calls the network 503A, while a portal page calls the named pharmacies 503B. When we checked the FDA’s registered 503B outsourcing-facility list, updated August 25, 2026, neither CraftedRx nor ChemistryRx appeared by that exact name.

Let’s take this carefully, because it’s the most consequential thing we found and we want to be fair about it.

First, the good part

Direct Meds actually tells you which pharmacy it says will fill your prescription based on where you live. Many compounded GLP-1 programs do not name a pharmacy before enrollment. This is useful transparency and they deserve credit for it.

Here’s the full provider-stated map from the Direct Meds portal page, verified August 27, 2026:

CraftedRx — 609 N State Hwy 47, Suite C, Warrenton, MO 63383 · (888) 788-0485
Fills for: Alaska, Arkansas, Arizona, Colorado, Delaware, Florida, Georgia, Hawaii, Iowa, Idaho, Illinois, Indiana, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, DC, West Virginia, Wisconsin, and Wyoming.

ChemistryRx — 950 Henderson Blvd, Folcroft, PA 19032 · (877) 989-6128
Fills for: Alabama, California, Connecticut, North Carolina, South Carolina, and Washington.

The portal page marks as not served: Mississippi and Louisiana. A separate current Direct Meds offer page says only Mississippi is excluded.

That is another live disclosure conflict. The pharmacy map is provider-stated. We did not independently verify every state license, nonresident permit, current dispensing relationship, or Louisiana availability.

Now the part we checked

Two current Direct Meds pages tell two different stories:

Those are not two spellings of the same thing. 503A and 503B are different legal paths.

What 503A means: A traditional compounding pharmacy generally prepares medication for an identified patient after receiving a valid prescription. State pharmacy boards are central regulators, and federal conditions still apply.

What 503B means: An outsourcing facility voluntarily registers with the FDA, can compound certain drugs in batches under section 503B, follows current good manufacturing practice requirements, and appears on the FDA’s public registered-outsourcing-facility list.

Neither one means the FDA approved the medicine. Registration is not approval. Direct Meds’ use of the word “approved” for a compounding facility or product is not the same as FDA drug approval.

The FDA publishes the registered 503B list on fda.gov. We pulled the version updated August 25, 2026, two days before this review.

Here’s what we found:

What this does and doesn’t mean

We want to be careful here, because there are innocent explanations and we’re not going to pretend otherwise.

It might be a legal-name difference. Companies can register under a legal entity name that differs from a trade name. Nexgen Formulations is in the same Pennsylvania town as ChemistryRx. We found no public source in this audit proving that Nexgen is the legal entity behind ChemistryRx, so we are not claiming it is.

It might mean the named pharmacy is operating under 503A, not 503B. A pharmacy can be licensed and legally compound patient-specific prescriptions without appearing on the FDA’s 503B list. Absence from the 503B registry does not prove that a pharmacy is unlicensed or that a prescription is unlawful.

What is proven is the disclosure conflict. One Direct Meds page says 503A. Another says 503B. The exact names it publishes do not appear on the current 503B list. That is enough reason to ask for the legal entity and section in writing.

There is one more twist. The FDA’s April 2026 proposal concerns 503B use of bulk semaglutide, tirzepatide, and liraglutide. That proposal was not final when we checked, but it makes the 503B answer more important, not less. A 503A answer has its own exact-copy and patient-specific rules. Neither path is a blank check.

What you should do: Ask, in writing, before you pay:

“What is the exact legal name and state license number of the pharmacy filling my prescription? Is it filling my prescription under section 503A or section 503B? Is this being prepared for me as an identified patient?”

A good answer is a specific legal name and license you can look up. A vague answer is your signal to slow down.

Primary source: FDA Registered Outsourcing Facilities, updated August 25, 2026. Direct Meds pharmacy map and 503A/503B statements verified on company pages August 27, 2026.

👉 Check whether Direct Meds lists service in your state

Your state affects which pharmacy Direct Meds says will fill the prescription. Open the current intake, confirm that your state is served, and ask for the exact pharmacy before you submit payment.

Check current state availability →

The portal currently marks Mississippi and Louisiana unavailable, while another Direct Meds page excludes only Mississippi. Confirm your state in the live intake.

Why is Direct Meds 4.6 on Trustpilot but 1.92 on the BBB?

Both scores were live when we checked, but you cannot treat them as two controlled samples of the same crowd. Trustpilot showed 4.6 out of 5 from 14,477 reviews, said Direct Meds invites customers to review, and noted that the profile was merged with one or more other profiles belonging to the company. The BBB showed 1.92 out of 5 from 367 customer reviews, plus 272 complaints in three years. Neither score proves medication quality, safety, or effectiveness.

This is the split that sends people searching in the first place. Here’s the honest explanation.

Think about what that means. Trustpilot tells us the company actively asks customers to review. BBB tells us how many people used its review and complaint systems. Neither platform gives us a random sample of every patient. The giant gap is real, but neither average deserves to be treated like a clinical result.

That’s not a reason to ignore the scores. It’s a reason to read what sits underneath them.

What the 272 BBB complaints are actually about

We pulled the full live category breakdown. This is more useful than the score:

Percentages are rounded, so they may not add perfectly.

The categories lean heavily toward product, service, billing, and delivery disputes. The published complaint text includes allegations about unexpected 90-day shipments, remaining balances, cancellation friction, support delays, delivery, and unwanted messages.

Those are customer allegations, not proven findings. BBB also warns that published text may not show every complaint and that some details may be withheld or shortened.

And this data cannot answer a clinical question. A billing complaint file does not prove a medication is safe, unsafe, potent, weak, sterile, or contaminated. It tells you where commercial friction is showing up.

The trend worth watching

Here’s something more useful than picking the newest ten reviews and declaring the problem fixed.

Trustpilot says 11,540 of the 14,477 reviews arrived in the last 12 months. That is a very fast rise in review volume. Trustpilot also says the company invites customers to review and that the profile was merged with other company profiles.

BBB says 238 complaints were closed in the last 12 months, while 89 of the 272 total complaints show “Resolved” and 183 show “Answered.” That tells us the company is responding through the BBB system. It does not tell us that every customer agreed with the answer.

Our read: Direct Meds is actively collecting reviews and actively answering complaints. That may improve the visible trend. It does not erase older billing stories, and it does not prove the underlying medication or service got better. The plan language at checkout is still the part you can control.

What real customers said

Three dated examples, with the limits left on:

Lauren S — BBB, August 19, 2026 — Reported 15 months in the program, 55 pounds lost, no longer being in the obese range, and an A1C back in the normal range. She said she would recommend Direct Meds.

Recent Trustpilot support theme — Reviewers describe representatives helping with billing, login, subscription, and cancellation questions. Trustpilot’s current summary also notes that some reviewers reported warm packages, unanswered questions, or results that fell short of expectations.

BBB complainant — August 6, 2026 — Said they paid $147 expecting one month, received three months in one shipment, and learned that the second installment would be $297. Direct Meds answered that it offers 90-day subscription programs with later installments.

The first BBB review page displayed ten reviews dated August 19 through August 24, 2026, and all ten were favorable in their written text. That is a real dated snapshot. It is also only ten reviews on one page, so we did not use it to declare the older billing problem fixed.

Individual results vary. This selected result does not show what a typical customer should expect. Reviews are customer accounts, not evidence of medical safety or effectiveness. Weight Loss Provider Guide has an affiliate relationship with Direct Meds.

Sources checked August 27, 2026: Direct Meds on Trustpilot; BBB customer reviews; BBB complaints.

How does Direct Meds actually work?

Direct Meds uses an online flow where you choose a product, submit payment on at least some current checkout paths, then complete a medical intake that a licensed provider reviews. If approved, a partner pharmacy prepares and ships the medication. Direct Meds says a provider denial gets a full refund. The company’s own pages show two different orders — one graphic puts the intake before provider review and delivery, while the checkout FAQ says you pay first and complete the intake after.

Read that last sentence again. There’s an order-of-operations detail in there that surprises most people.

You may pay before the provider reviews you

The current sublingual portal FAQ says the customer has “selected and paid for the first month” before completing the intake for a clinician to review. The step list on that same page also puts payment before the intake and provider review.

But higher on the page, a three-step graphic says:

1. Complete the medical intake.
2. A provider reviews it.
3. If prescribed, the pharmacy ships.

Those two sequences are not identical. The checkout FAQ is the clearest written instruction about payment, so assume payment can happen before clinical approval unless the live flow in front of you clearly shows otherwise.

This is different from telehealth services that clear you clinically before collecting a medication payment. Neither order is automatically unlawful. But you should know which one you’re entering.

The safety net: Direct Meds says you receive a full refund if the provider does not approve the prescription. That promise appears on current offer and portal pages. If you are denied, save the denial message, ask for the refund confirmation in writing, and watch for the credit to post.

The rest of the flow

Product and plan choice. You pick semaglutide or tirzepatide, injection or a listed sublingual option, and whatever plan choices are offered for your state.

Health qualifier and intake. You answer questions about your health history, medications, and goals. Current pages disagree on whether the qualifier happens before or after the first payment, so read the live sequence.

Provider review. A licensed provider decides whether treatment is appropriate and sets the prescription and dose. Direct Meds says this is expected within 24 hours and often takes less than five hours. That is the company’s target, not a time we tested.

Pharmacy fills it. Direct Meds says the prescription goes to CraftedRx or ChemistryRx based on your state. Ask for the exact legal pharmacy name before relying on that map.

Shipping. One current FAQ says approved medication ships within two business days. Another says prescriptions received before 2 p.m. Central ship the same day, next-day by UPS in temperature-controlled packaging, while Friday through Sunday orders ship Monday. Those are provider-stated shipping targets. We did not order or time a package.

Refills and dose changes. Direct Meds says you contact the provider through the portal when you are running low, and the provider reviews whether the dose should change before writing the next prescription.

One thing to double-check with your provider

The sublingual page tells you several different dosing and administration stories.

• The dose selector offers 1 mg/day and 0.25 mg/day.
• The Benefits section says “Once-weekly dosing.”
• The portal FAQ says to hold the drops under the tongue for 45–60 seconds, take them once daily in the morning, and avoid food or drink for 30 minutes.
• Another current Direct Meds offer page says to hold sublingual drops for one to two minutes and avoid eating, drinking, or smoking for 15 minutes before and after.

The page has more than one daily cue, while “once weekly” looks copied from injection language. But a marketing-page majority vote is not a prescription.

Follow only the pharmacy label and the instructions from your prescribing provider and dispensing pharmacist. Never dose from a marketing page. If the bottle, portal, provider message, and website disagree, stop and call the pharmacy before the first dose.

Are Direct Meds compounded GLP-1 medications safe?

No public review page can tell you that a particular compounded vial or bottle is safe. FDA-approved semaglutide and tirzepatide labels commonly list nausea, diarrhea, vomiting, constipation, abdominal symptoms, and fatigue, and they carry a boxed warning about thyroid C-cell tumors seen in animals. Direct Meds prints the MTC and MEN 2 warning on current pages. A compounded product adds another fact: the FDA did not review that exact finished preparation for safety, effectiveness, or quality before it was sold.

Direct Meds tells people not to use a GLP-1 if they or their family have a history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. That matches a major contraindication in FDA-approved semaglutide and tirzepatide labeling. Take it at face value.

The animal finding does not prove these drugs cause thyroid cancer in humans. The approved labels say the human relevance is unknown. The contraindication still applies to people with a personal or family history of medullary thyroid carcinoma or MEN 2.

What your intake should ask about

Tell your provider about all of these, even if the form does not ask clearly:

• Personal or family history of medullary thyroid carcinoma, or MEN 2
• Pancreatitis or gallbladder problems
• Kidney problems, or a history of getting dehydrated easily
• Diabetes, especially if you use insulin or a sulfonylurea
• Eye problems related to diabetes
• Severe stomach-emptying problems or major digestive disease
• Pregnancy, breastfeeding, or trying to conceive
• Any surgery, procedure, or anesthesia coming up
• Any semaglutide, tirzepatide, or other GLP-1 product you already use
• Every prescription, over-the-counter drug, and supplement you take

A checkbox form is not the place to minimize your history. The provider can only screen what you tell them.

The dosing risk that’s specific to compounded products

This is worth a paragraph on its own.

Many FDA-approved injection pens are premeasured or use fixed product-specific dose systems. Compounded injections may come in a multi-dose vial that you measure with a syringe. The FDA has received reports of dosing errors with compounded semaglutide, including errors that required hospitalization. The agency points to different concentrations, confusing conversions between milligrams and “units,” and mistakes by both patients and health professionals.

Different pharmacies can use different concentrations. So “20 units” from one vial does not automatically equal “20 units” from another.

Before your first injection, have the provider or pharmacy show you the exact milligrams prescribed, the concentration on your exact vial, and the exact syringe mark to use. Repeat it back. Photograph the written directions. Do not copy a dose from a friend, forum, social post, or old bottle.

That is a preventable risk, and one phone call can remove much of the confusion.

Check the box when it lands

If a longer supply arrives in one shipment, this matters even more:

• Is an injectable package still cold enough under the pharmacy’s written storage rules? The FDA says not to use an injectable GLP-1 product that arrives warm or with too little refrigeration; contact the pharmacy.
• Does the prescription label show your name, the legal pharmacy name, the drug, concentration, directions, and beyond-use date?
• Does the label say what form you were promised — injection, tablet, or sublingual liquid?
• Is the seal intact, and are the vial, bottle, syringe, and packaging undamaged?
• Does the amount shipped match the supply length on your receipt?
• Did the pharmacy include a number for medication and storage questions?
• Can children reach it? Direct Meds’ terms say prescriptions do not use child-resistant packaging, so lock the medication away.

The terms give you 48 hours from receipt to report a product problem covered by the return policy. Photograph the package, temperature indicator if present, label, medication, and damage the same day.

That 48-hour contract window is not a medical-care deadline. Seek urgent care now for a severe allergic reaction, trouble breathing, severe or lasting abdominal pain, repeated vomiting with dehydration, or another serious symptom. Do not wait for customer support to answer an emergency.

For a broader checklist, read our guide to getting a GLP-1 online safely.

This page is not medical advice and cannot tell you whether a GLP-1 is right for you. Only a licensed clinician who reviews your history can do that.

Primary sources: FDA concerns with unapproved GLP-1 drugs; FDA overview of compounded-drug risks; current FDA-approved prescribing information for semaglutide and tirzepatide products.

Who should use Direct Meds, and who should skip it?

Direct Meds can fit a cash-paying adult who wants one of its compounded options, values a published starting price of $249, and is willing to verify the exact plan and pharmacy. It is a poor fit for anyone who wants an FDA-approved brand by name, wants to use insurance, or wants one clean month with no chance of a longer balance unless the checkout explicitly offers that.

Find yourself in this table. Then act on that row and ignore the rest.

Only proceed if all five are true

Be honest with yourself here. If you can’t check all five, don’t pay yet.

1. ☐ I understand this medication is compounded, not FDA-approved.
2. ☐ I know whether I selected month-to-month, 90 days, or another term, and how much medication ships now.
3. ☐ I know the amount charged today, every later charge, and the total plan cost.
4. ☐ I know the cancellation deadline and whether any plan balance would remain.
5. ☐ I know the pharmacy’s exact legal name, state license, and whether it is filling under 503A or 503B.

That’s the whole test. Five boxes.

👉 If that first row is you, this can be a legitimate way to do it

Cash-pay, comfortable with compounded medication, and willing to read the plan before paying. Now you know the questions most people do not ask until after the box arrives.

Open the Direct Meds eligibility and pricing flow →

Stop before payment and record the plan. Nothing should ship unless a licensed provider prescribes it. Compounded medications are not FDA-approved.

If you want Wegovy, Zepbound, or another approved product by name, or you want to try insurance, don’t force this one.

See FDA-approved options and current pricing through Ro →
Ro currently charges two separate amounts: membership is $39 for the first month, then $74–$149 per month depending on prepayment; medication costs extra and currently starts at $149 for certain options.

Direct Meds vs. the alternatives

The right alternative depends on why Direct Meds isn’t working for you. If it’s the compounding question or insurance, you need an FDA-approved brand route. If it’s the billing structure, you need a cash-pay program with clearer plan terms. Those are different problems with different answers.

When paying more is the smarter buy. If reading the FDA warning-letter section made you uneasy, that is a completely rational reaction, and the fix is simple: choose an FDA-approved product instead. An approved product has an FDA-approved label, a defined manufacturer, and evidence tied to the exact product. You may pay more. You also stop having to ask whether the finished medicine itself was FDA-approved.

That’s a real trade, and plenty of people should take it.

If your problem is only the plan structure, not compounding itself, compare flat-rate compounded GLP-1 programs before switching lanes entirely.

Ro pricing and availability verified August 27, 2026. Membership and medication are separate charges. Offers, doses, eligibility, and insurance coverage can change.

What to confirm before you pay Direct Meds

Screenshot the checkout screen before you submit payment. Confirm the selected plan, supply length, amount charged today, total across all payments, whether the full supply ships at once, the cancellation deadline, that the medication is compounded rather than FDA-approved, and the exact legal name of the pharmacy filling your prescription.

Nine things. Ten minutes. It’s the cheapest insurance you’ll ever buy.

Ask these seven questions:

1. What is charged today?
2. What is charged next, on what date, and what is my total plan cost?
3. Is this month-to-month, a 90-day supply, or another subscription term?
4. How much medication ships now, and if I cancel tomorrow, what do I still owe?
5. What exact drug, formulation, concentration, dose unit, and dosing schedule am I getting?
6. What is the pharmacy’s exact legal name and state license number, and is my prescription filled under 503A or 503B?
7. What happens if I am denied, or the package arrives late, warm, damaged, or mislabeled?

Then screenshot these two things:

8. The checkout screen showing the plan name, supply length, today’s charge, every future charge, and cancellation language.
9. The address bar, confirming you are on directmeds.com.

Get the answers in writing. Email or portal messages beat a phone memory. If the page changes between the ad, qualifier, and final checkout, screenshot each version.

If a company won’t put the plan and total in writing, that tells you something all by itself.

What we actually verified

Last verified: August 27, 2026

What we did. We read Direct Meds’ homepage, weight-loss pages, current semaglutide and tirzepatide offer pages, live sublingual semaglutide and tirzepatide portal pages, pharmacy map, and the full Terms & Conditions dated April 16, 2026. We read the FDA warning letter to directmeds.com, Inc. dba DirectMeds, MARCS-CMS 716822, dated September 9, 2025. We pulled the FDA’s registered 503B outsourcing-facility list updated August 25, 2026 and searched it for both pharmacy names Direct Meds publishes. We reviewed the BBB business profile, customer-review score, complaint totals, category counts, complaint statuses, and company responses. We recorded Trustpilot’s score, exact review count, last-12-month count, invitation label, and merged-profile notice. We checked the FDA’s current published position on compounded semaglutide and tirzepatide and Ro’s current pricing page.

What we confirmed at the source. The current listed Direct Meds prices; the 90-day portal wording; the separate month-to-month and subscribe-and-save statement; every contract clause described; the FDA warning letter; the live FDA-approval contradiction; the live 503A/503B contradiction; the exact-name result on the FDA 503B registry; the BBB and Trustpilot figures; the pharmacy map Direct Meds publishes; the state-availability conflict; and Ro’s two-charge pricing structure.

What we could not confirm. Whether Nexgen Formulations is the registered legal entity behind ChemistryRx. Whether CraftedRx or ChemistryRx currently fills a given prescription under 503A, 503B, or a different legal entity name. Whether the FDA issued a close-out letter for the September 2025 warning letter — we did not find one, and that is not proof Direct Meds failed to respond. Whether the FDA finalized its April 2026 503B bulks-list proposal after the July 30 comment deadline — we found no final notice in the official sources searched through August 27. Current LegitScript status beyond the certification claim displayed on Direct Meds’ site. The exact plan choices shown to every buyer, because product, state, promotion, and checkout path can change the screen.

What we did not do. We did not enroll, submit health information, pay, receive a provider decision, purchase medication, inspect a package, test the medication, test a refund, or call customer support for this review. Everything above comes from published documents and public pages, all dated. No medical professional reviewed this page, and we don’t claim one did.

Our relationship. Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We have an affiliate relationship with Direct Meds and may earn a commission if you enroll through our links. We published the FDA warning letter, the pharmacy-registry result, the 503A/503B conflict, and the billing conflict anyway. That’s the deal we make with you.

Corrections. Found something wrong? Tell us and we’ll fix it and note the date.

Primary sources used for this review

• FDA warning letter to directmeds.com, Inc. dba DirectMeds — September 9, 2025
• FDA: Concerns with unapproved GLP-1 drugs used for weight loss
• FDA: Policy for compounders after national GLP-1 shortages
• FDA: April 30, 2026 proposal on semaglutide, tirzepatide, and liraglutide for the 503B bulks list
• Federal Register: Comment-period extension through July 30, 2026
• FDA Registered Outsourcing Facilities
• Direct Meds Terms & Conditions
• Direct Meds sublingual semaglutide portal page
• Direct Meds tirzepatide portal page
• Direct Meds promotional offer page
• BBB business profile for Direct Meds LLC
• Trustpilot profile for Direct Meds
• Ro weight-loss pricing
• IRS Publication 502 — weight-loss program rules

Frequently asked questions

Is Direct Meds legit?
Yes. It is a real operating telehealth company, not an anonymous storefront. The FDA warning letter identifies directmeds.com, Inc. dba DirectMeds in Bluffdale, Utah. The BBB lists Direct Meds LLC in Salt Lake City with a May 6, 2024 start and incorporation date. Real does not mean every page is accurate: Direct Meds received an FDA warning letter in September 2025, and its current pages conflict on plan terms, state availability, and pharmacy type.

Is Direct Meds FDA-approved?
No. A company is not “FDA-approved” in the same way a drug is. The Direct Meds semaglutide and tirzepatide products reviewed here are compounded and are not FDA-approved drugs. Some current Direct Meds product copy still makes an FDA-approval claim, which conflicts with its other disclosures and the FDA’s rule. Ask for written confirmation that the exact product is compounded before paying.

How much is Direct Meds per month?
Current listed prices are $249 a month for sublingual semaglutide, $297 for semaglutide injections, and $399 for tirzepatide injections. Promotions advertise a first month around $147 for semaglutide and $199 for tirzepatide. The number you need is the full plan total, not only the first charge.

Does Direct Meds offer a month-to-month plan?
Direct Meds says yes. A current official offer page says month-to-month pricing has no contract, and a company response on BBB says a month-to-month option exists. But the live sublingual semaglutide and tirzepatide portal pages we opened showed a 90-day supply billed monthly. Choose only a checkout that clearly names the plan you want and save the screen.

Is Direct Meds a subscription?
Certain plans are. Direct Meds’ Terms & Conditions section 5 is titled “Subscription Products” and describes recurring charges. The company also says it offers month-to-month and subscribe-and-save choices. “No Monthly Membership” means there may be no separate access fee; it does not mean the medication plan never renews.

Does Direct Meds really send three months at once?
Direct Meds says it can when a 90-day commitment is selected. In company responses on BBB, it described 90-day subscription programs with later installments and explained that a selected 90-day commitment can ship up front and bill monthly. That is not necessarily the structure of a true month-to-month plan. Confirm the supply shipped and the remaining balance for your exact checkout.

How do I cancel Direct Meds?
Turn off auto-refill in the patient portal before the 48-hour cutoff, screenshot it, email help@directmeds.com, and call (888) 696-7176. Ask for the effective cancellation date, final shipment, final charge, and any remaining plan balance in writing. The terms say a prescription order may be stoppable within 24 hours if it has not reached the provider network, but medication already received is generally not refundable.

Why does Direct Meds have a low BBB customer-review score?
The BBB showed 1.92 out of 5 from 367 customer reviews and 272 complaints in three years when checked August 27, 2026. The largest complaint categories were product issues, service or repair issues, billing issues, and delivery issues. Customer complaints are allegations and do not establish clinical safety or medication quality.

Does Direct Meds take HSA or FSA?
Direct Meds says it accepts HSA and FSA payments. A card being accepted does not prove the expense is eligible under your plan. IRS Publication 502 says weight-loss expenses may qualify when they treat a specific disease diagnosed by a physician, such as obesity or hypertension, but not when the purpose is general health or appearance. Confirm with your plan administrator and keep the prescription, diagnosis support, receipt, and any requested letter of medical necessity.

What pharmacy does Direct Meds use?
Direct Meds’ portal names CraftedRx in Warrenton, Missouri for 42 states plus Washington, DC, and ChemistryRx in Folcroft, Pennsylvania for six states. One Direct Meds page calls the network 503A; another calls it 503B. Neither pharmacy name appeared exactly on the FDA’s registered 503B list updated August 25, 2026. Ask for the pharmacy’s exact legal name, state license, and 503A or 503B status.

What states does Direct Meds serve?
The live portal map says Direct Meds serves 48 states plus Washington, DC and excludes Mississippi and Louisiana. A separate current offer page says only Mississippi is excluded. Treat both as provider-stated and confirm availability in the live intake before entering payment information.

How long does Direct Meds take to ship?
Direct Meds says approved prescriptions ship within two business days. Another current FAQ says prescriptions received before 2 p.m. Central ship the same day by next-day UPS, while Friday through Sunday orders ship Monday. Those are company targets, not delivery times we tested.

Is Direct Meds the same as Ozempic, Wegovy, Zepbound, or Mounjaro?
No. Those names refer to FDA-approved products made under their approved applications. Direct Meds sells compounded semaglutide and tirzepatide through the programs reviewed here. The FDA’s September 2025 warning letter was specifically about language that made compounded products sound the same as approved products.

What is the “DM2*Directmeds” charge on my card?
That is the billing descriptor listed in Direct Meds’ Terms & Conditions. If you did not expect it, check whether auto-refill is on, which plan you selected, how much medication already shipped, and whether a longer plan balance remains.

Can I get a refund from Direct Meds?
Only in limited cases under the current written policy. Direct Meds promises a full refund if its provider denies the prescription. The terms also list incorrect medication, damaged products, products that do not meet safety standards, unshipped products, and provider denial as possible return or refund situations. Report a product issue within 48 hours. Returned prescription medication may carry a $35 disposal fee.

Can I fill a Direct Meds prescription at my local pharmacy?
Not under the current terms. Section 6 says that by purchasing, you waive the right to fill the prescription at another pharmacy.

Why am I getting Direct Meds texts I never signed up for?
BBB complaints include people alleging repeated unwanted messages. Direct Meds’ terms say SMS consent is optional and tell recipients to text STOP to unsubscribe, text HELP, call (833) 949-8998, or email help@directmeds.com. If STOP does not work, keep screenshots and dates, contact the company in writing, and use your carrier’s spam-reporting tools or the complaint channel that fits your situation.

Still not sure which GLP-1 program is right for you?

You’ve now read the contract, the warning letter, the complaint file, the live product copy, and the FDA pharmacy registry. That’s more homework than most people do before starting a GLP-1, and you should feel good about that.

If you’re still weighing compounded against FDA-approved, cash against insurance, or drops against injections, don’t guess. About two minutes gets you a straight path based on eight questions.

Take our free GLP-1 matching quiz →

Get your personalized GLP-1 action plan. No provider pressure and no email required.

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. This page is for information only and is not medical advice. Compounded medications are not FDA-approved. Only a licensed clinician can determine whether a GLP-1 medication is appropriate for you. Individual results vary.